Is Albiglutide legal in the US?
Yes, FDA approved for type 2 diabetes, but it is no longer sold.
Albiglutide was FDA-approved in April 2014 as Tanzeum, a once-weekly injection for adults with type 2 diabetes. GlaxoSmithKline withdrew it from the market in 2018 for commercial reasons, not safety, so the approval exists but no product is sold. 13
It was approved in 2014 for type 2 diabetes. The approval was never revoked for safety reasons. The manufacturer stopped selling Tanzeum in 2018, so it is not available. 13
No. The albumin-fusion protein is made by recombinant biotechnology. A compounding pharmacy cannot produce it. No generic or biosimilar exists. 1
Read the full Albiglutide page
More on Albiglutide
Citations
- Fala 2015, Am Health Drug Benefits: Tanzeum (albiglutide), a once-weekly GLP-1 receptor agonist approved for type 2 diabetes pmc.ncbi.nlm.nih.gov
- Hernandez 2018, Lancet: HARMONY OUTCOMES, albiglutide and cardiovascular outcomes in type 2 diabetes doi.org
- Drugs.com: Tanzeum (albiglutide) discontinuation drugs.com
Reference information only, not medical advice. Drawn from the Albiglutide article, fact-checked against the cited sources. No dosing anywhere on this site.